Key facts
- Augmedi’s last known valuation is $2.6M (Feb 2025).
- It has raised $440K; the latest was Early Stage VC in Oct 2025.
- Notable investors include HGS START accelerator, Balgrist Beteiligungs.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Augmedi
- ·The full record, as it builds
Funding rounds
No funding rounds for Augmedi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Augmedi
Developer of medical e-learning technology designed to enhance anatomical education and clinical preparation for healthcare professionals. The company's platform features photorealistic three-dimensional models of human anatomy, AI-driven performance analysis, interactive orthopedic modules, exam preparation tools, and multi-device accessibility, enabling medical students, doctors, hospitals, and universities to accelerate learning, improve retention, and bridge the gap between textbook illustrations and real-life clinical practice.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Zurich, Switzerland
- Founded
- 2023
- Employees
- 10
- Website
- augmedi.com/
- Ownership
- Privately Held (backing)
Augmedi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Augmedi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Augmedi in its N-PORT filings yet. We sweep new filings monthly.